Treatment of Temporomandibular Joint Syndrome in Myogenous Temporomandibular Disorder
Clinical scenario
This protocol covers temporomandibular joint syndrome (TMJ syndrome) in patients with a diagnosis of myogenous temporomandibular disorder — a specific clinical subtype of painful TMD.
Treatment goals
The primary targets are meaningful reduction in pain intensity and a decrease in pain-related disability.
First-line approach
Evidence supports a supported self-management (SSM) plan developed collaboratively with a primary care practitioner as the first-line intervention — incorporating a structured combination of patient-directed strategies. The complete, sequenced regimen is accessible via the link below.
References
- All individuals diagnosed with painful TMD (any sub diagnosis) should be actively involved in the development of a supported self-management (SSM) plan with their primary care practitioner.
- SSM has been shown to support reduction in pain intensity and pain related disability with no reported adverse effects, suggesting favorable risk: benefit ratio, for low economic cost.
- Evidence suggests acupuncture or dry needling for individuals with myogenous TMD is likely to have a positive effect on pain symptoms.
View source ↗